Dawd S. Siraj,MD, MPH retweeted
Join us in welcoming new faculty member, Kevin Gregg, MD, visiting professor, Infectious Disease, who brings expertise in transplant ID and quality improvement!
Get to know Dr. Gregg: ow.ly/t4tt5103yhz
Dawd S. Siraj,MD, MPH retweeted
Congratulations to Dr. Tischendorf, a top-tier mentor for faculty and learners! @UWHealth @uwsmph @uw_medicine
The World Series Champions!! A dominant overall team! What a series! Let’s go Brewers! Congratulations Wisconsin!
Dawd S. Siraj,MD, MPH retweeted
Congrats to David Andes, MD, William A. Craig Endowed Professor and division chief, and Alexander Lepak, MD, associate professor, both @uw_infdisease, on being named to positions within the CLSI Subcommittee on Antifungal Susceptibility Tests.
Dawd S. Siraj,MD, MPH retweeted
On, Wisconsin!
#UWMadison rises to #8 among public universities in the latest @usnews rankings — our highest in ranking the Best Colleges report in close to two decades — and is among the top 5 schools in the U.S. ranked best value for in-state students.
news.wisc.edu/uw-rises-to-8t…
Dawd S. Siraj,MD, MPH retweeted
Congratulations to @davidrandes on his recent appointment as Chair of the Clinical Laboratory Standards Institute!
A trend has been going on for some time- oral vs IV antibiotics for high consequence infections: A slippery slope to what is trending without enough evidence. Most supporting evidence to treat IE and SA bacteremia with oral antibiotics is retrospective & observational.
There are few prospective trials - but have significant methodology/ statistical flaws. Most have a long lead-in IV antibiotics nullifying the claim of equivalence. ID society should demand high quality evidence to change practice.
3/3-
@CIDJournal @OFIDJournal or @NEJM should identify leaders in the field to review the data. The trend of moving to oral antibiotics in such high consequence infections is to say the list concerning! the review available is all one sided that minimizes flaws to drive a point


































